Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Pfizer - Biontech - Dermapharm
View:
Post by Solid1 on Dec 18, 2021 6:59am

Pfizer - Biontech - Dermapharm

And the acquisition of Dermapharm regarding C3 from Canopy Growth should also be looked at more closely....Pfizer - Biontech - Dermapharm are partners which tells me that the topic of cannabinoids is hotter than the market wants to make it seem ;-) 
and so far all roads lead (not to Rome) but to Medipharm Labs. 
Comment by Solid1 on Dec 18, 2021 8:10am
I would be really interested to know who owns the 50 million shares that Medipharm Labs issued during the last capital increase at the beginning of March. 
Comment by mcamm10 on Dec 18, 2021 9:18am
This post has been removed in accordance with Community Policy
Comment by alleyesonme on Dec 18, 2021 9:58am
The world is realizing vaccines are not the solution treatment is. It is becoming evident effective treatment is cannabinoid based. Labs may not be the label of this treatment however their expertise in extraction will surely be called upon and needed to assist in worldwide supply. It's possible big things are happening behind the scenes since CEO's share purchase, big enough insiders are ...more  
Comment by Solid1 on Dec 18, 2021 10:08am
I also think that Labs is a takeover target but only at what price... the current price is depressed and the true value should remain hidden 
Comment by mcamm10 on Dec 18, 2021 10:15am
This post has been removed in accordance with Community Policy
Comment by alleyesonme on Dec 18, 2021 10:45am
Its not a question of "access" ...it's a question of ability....if safe, effective treatment for covid is cannabinoid based proprietors will give access to any company capable in order to produce the API's to bring treatment to the world A.S.A.P.....covid aside LABS has to be a target for takeover and depending on who's accumulating, hostile isn't outta the question ...more  
Comment by Solid1 on Dec 18, 2021 11:07am
Hedge funds and insiders currently hold almost 44% of the shares, making a hostile takeover difficult. 
Comment by alleyesonme on Dec 18, 2021 11:19am
My info says 18% institution, 6% insider...still difficult but you'd be surprised....either way happy to hold at 23c average.
Comment by Solid1 on Dec 18, 2021 11:24am
In my calculation, the 50 million from the last capital increase, which are held by Mister X, are still flowing. And according to my current status, it is 20.03% Institution https://www.morningstar.com/stocks/pinx/medif/ownership
Comment by alleyesonme on Dec 18, 2021 11:36am
Thanks solid1...gotcha...def interested to know who owns that 50m.....to say a takeover possibility is bull when the market cap is almost the cash on hand is crazy on a company with years of legwork completed on the international stage. If the SP doesn't dramatically improve the sharks will roll inn with chumpchange..... I suspect they are already circling.
Comment by Solid1 on Dec 18, 2021 11:53am
They can circle all they want, if they want to take over the company, they will have to buy out the market. 
Comment by alleyesonme on Dec 18, 2021 12:02pm
Precisely...what price would do it....buck a share after 17 cent close...chump change to the big boys....yeppers....see what happens...
Comment by mdjbrown on Dec 18, 2021 2:18pm
S1, dont forget the 57,5 million attached warrants either if the share price can move above .70 cents. Control of 115 million common shares of Medipharm if exersized is nothing to sneeze at. MediPharm Labs Corp. (“MediPharm”), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a bought deal ...more  
Comment by mcamm10 on Dec 18, 2021 11:16am
This post has been removed in accordance with Community Policy
Comment by mcamm10 on Dec 18, 2021 9:11am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities